Codeprex Approval History
- FDA approved: Yes (First approved June 21st, 2004)
- Brand name: Codeprex
- Generic name: chlorpheniramine polistirex and codeine polistirex
- Dosage form: Extended Release Suspension
- Company: Celltech Group plc
- Treatment for: Cough
Codeprex (chlorpheniramine polistirex and codeine polistirex) is an antihistamine and cough suppressant combination for the treatment of cough.
Development History and FDA Approval Process for Codeprex
|Jun 21, 2004||Codeprex Celltech Group plc - Treatment for Cough|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.